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Summary Background: Although allergy is central to the pathophysiology of asthma,
little is known about the benefits of a structured approach to allergen diagnosis and
management in primary care asthma patients.
Objectives: We studied effects of a structured allergen evaluation and allergen
avoidance advice combined with or without additional allergy skin testing on health
status, illness perception, and lung function of asthma patients treated in general
practice.
Method: Fifty-four asthma patients were randomly assigned to three groups: (i)
Standard asthma care with information on the stepwise treatment approach, a
written action plan, and inhaler technique training; (ii) Additional structured allergen
evaluation and avoidance advice; (iii) Additional structured allergen evaluation and
avoidance advice based on skin prick test results. Patients were seen for one initial
appointment at a primary care asthma clinic and a follow-up examination 3 months
later. On both occasions, questionnaire measures of symptoms, illness perception,
and the perceived control of asthma were administered. Lung function was measured
by spirometry (PEF, FEV1). Perceived allergic asthma triggers, the trigger impact, and
the trigger control were assessed in both intervention groups.
Results: Following intervention, a decrease in beta-adrenergic inhaler use, an
increase in the perceived control of asthma, and a decrease in the bothering from
asthma symptoms were observed for all three groups. Intervention groups showed a
higher awareness of animal-allergic triggers, and the perceived control of asthma
triggers was increased in the group receiving no skin tests. FEV1 showed an
improvement in both intervention groups.
Conclusion: Structured allergy evaluation and avoidance advice can improve lung
function and the control of asthma in primary care. Further research is needed on the
additional benefits of allergy skin testing.
r 2003 Elsevier Ltd. All rights reserved.
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Introduction
Patient education in the self-management of
asthma is widely recommended.1,2 It is essential
in building a partnership between patient and
health care professionals, to increase patients’
subjective and objective control of their chronic
condition.3 Education programs in self-manage-
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ment have been shown to improve functional status
in asthma and reduce health care utilization.4
Programs usually include multiple teaching ele-
ments and methods. It is now increasingly reflected
that there is a need to evaluate less complex
interventions in non-academic health care set-
tings,5 but little research is available on the
effectiveness of limited interventions. Offering
patients a limited choice of intervention elements
will lead to a greater flexibility by allowing to tailor
interventions for the individual patient. Recent
interview surveys have confirmed the need for a
more individualized approach to asthma manage-
ment.6,7
Allergic mechanisms are now generally accepted
as an important pathophysiological feature of
asthma.8 However, in general practice a systematic
approach to diagnosis and management of allergies
in asthma is often missing. Comprehensive material
is available to guide health care professionals,2,9
but the actual allergy assessment and avoidance
education to patients has remained largely un-
structured. Patients may be provided with informa-
tion material, but the abundance of information
can discourage the initiation of adequate steps for
prevention.10 Measures necessary for the avoidance
or control of allergens are then usually carried out
in an unsystematic fashion. Ideally, critical areas
and suggestions for control measures should be
negotiated between the health care professional
and the patient and should be included in the
regular treatment plan.
The skin prick test is a commonly used procedure
in secondary care for assessing a specific sensitiza-
tion in allergic respiratory diseases. Up to 85% of
asthma patients show positive reactions to skin
tests for common aeroallergens.11 Research has
demonstrated the reliability and predictive validity
of allergy skin testing.12–15 Skin testing for IgE
sensitivity to common allergens provides objective
information thus allowing a firmer diagnosis of
possible allergies. However, this is only achieved in
combination with careful subjective history taking.
Failure to use this combined approach could result
in deficiencies in diagnosis and asthma manage-
ment.16–18 Tschopp et al.15 recently concluded that
the skin prick test should be used as a primary tool
by clinicians to assess respiratory allergic diseases,
as the test is comparably economical and provides
immediate educational information for patient and
physician. Allergy skin testing can play an impor-
tant role in reducing the amount of specific
avoidance advice that nurses in general practice
give to patients.19
The present pilot study was designed to deter-
mine whether a structured allergen interview for
diagnosis and avoidance advice with or without
additional skin prick testing has the potential to
improve lung function, symptom experience, med-
ication usage, and perceived illness control of
asthma patients.
Materials and methods
Study design
The study was carried out in a repeated measure-
ment design with data collection at baseline and a
follow-up visit during a 10-month period from
November to August. The average interval between
first and second appointment was approximately 89
days, with SAC 87 days, SAA 92 days, SPT 87 days.
Patients were randomly assigned to three groups:
(i) Standard asthma care including medication
advice, inhaler technique training, spirometry,
and reversibility testing (SAC), (ii) additional
structured allergy assessment and advice (SAA),
and (iii) additional allergy assessment and advice
and skin prick testing (SPT). A specialist asthma/
allergy nurse who was not blind to the patients’
group allocation undertook treatments and out-
come measurements. Due to the pilot character of
the study, a blinded outcome assessors was not
feasible.
Patients
Random samples of 290 patients from a list of 1200
adult asthma patients registered in the practice
database were invited for a study on asthma and
allergy. Potential participants were selected from
the age range between 15 and 55 years to reduce
the risk of recruiting patients with chronic ob-
structive pulmonary disease (COPD). Seventy-one
patients responded, three were not eligible (two
men had COPD, one woman had prior experience
with skin testing) and eight women were randomly
excluded to reach a final sample of 60 patients,
which was then stratified into equal proportions of
women and men and randomized into three groups
(n ¼ 20). Seven patients dropped out at follow-up,
and one woman excluded earlier was recruited in
anticipation of dropout. Further recruitment was
not possible due to logistic reasons, so that a total
of 54 patients were included in the final analysis.
Patients had previously been treated for asthma at
the health centre by one of the general practi-
tioners, but had not been seen by the nurse
practitioner in the asthma clinic. None of them
had received education in the stepwise treatment
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approach,1 or in allergen avoidance measures.
Participation was voluntary, and it was made clear
to patients that their decision whether to take part
or not would not affect their regular treatment.
Informed consent was obtained from all patients.
The University Hospital Lewisham ethical review
committee approved the study.
Interventions
Patients were scheduled for individual 1–112-h
appointments at an asthma clinic in a primary care
health centre. Short- and long-acting bronchodila-
tors were discontinued prior to test sessions. All
patients underwent a full assessment of their
asthma on standard audit cards and a reversibility
test with spirometry. During reversibility testing,
skills at using the metered dose inhaler were
checked and re-education on technique and use
of reliever and preventer inhalers was given. Actual
spirometry readings were shown to the patient and
compared with the normal estimated range of
readings in an effort to improve the patients’
understanding of the procedure and to increase
treatment adherence. Information on reliever
medication use, inhaler technique skills, prescribed
medication, current smoking, and current restric-
tions at daytime and nighttime, and on activity, was
then entered in standard clinical audit cards (Allen
& Hanbury, Glaxo, UK). Advice was then given for a
stepwise approach to treatment 1,20,21 and a
personal self-management plan was agreed with
the patient. Patients then filled in a set of
questionnaires in a separate room. This included
demographics and asthma-related information (ill-
ness history, history of health care utilization,
medication use, and limitations on daily activities),
a questionnaire on asthma symptom frequency and
bother,22 the Perceived Control of Asthma Ques-
tionnaire,23 and the Illness Perception Question-
naire 24 adapted for asthma, with subscales for
illness consequences and illness time-line (degree
of perceived chronicity of asthma).
Both intervention groups SAA and SPT were
additionally administered the asthma trigger in-
ventory (ATI 25) and the structured allergy inven-
tory (SAI). The ATI is a checklist of perceived
asthma trigger factors, including allergic, meteor-
ological, exercise, irritant, and emotional triggers.
Scores for trigger impact and control were obtained
by averaging the ratings for the (up to) six triggers
reported as the patient’s main triggers. The SAI is a
combined structured interview and self-adminis-
tered questionnaire inventory on allergen history
and avoidance behaviors. It explores history, type,
frequency, duration, and perennial patterns of
allergic symptoms, trigger factors, and previous
treatments. Features of the home environment
which are potentially linked to allergens and non-
specific triggers (moulds, dust mite, pollen, pets,
smoking, indoor climate) are also explored.26
Patients are then asked to fill in a checklist of
allergen avoidance behaviors (house dust mite,
pets, pollens, indoors and outdoors mildew, non-
specific trigger factors) indicating which of these
measures they were familiar with (from standard
material provided by the British Allergy Founda-
tion, Welling, UK, and the UCB Institute of Allergy,
Watford, UK). For each problem area the portion of
the measures checked by the patient to measures
listed was calculated.
The SPT group then received skin prick tests, and
test results were discussed with the patients in the
light of their perceptions of triggers reported in the
SAI and ATI. Depending on the identified problem
trigger areas (assessed by self-report in SAA, or by
self-report and skin test in SPT) and reported
current avoidance skills, the practicality of indivi-
dual avoidance behaviors in the patient’s environ-
ment was discussed. Discussion of these and other
issues in trigger avoidance was not provided for SAC
patients.
Patients returned for a follow-up visit 3–6 months
later, for asthma assessment on audit cards,
spirometry testing, inhaler technique reassess-
ment, and questionnaires on symptoms and illness
perceptions. All patients filled in the ATI at this
stage. Patients of SAC and SAA were now offered
skin prick tests with reinforced allergen advice to
positive results and SAC patients were offered
additional allergen avoidance advice.
Lung function testing
Lung function (PEF, FEV1) was measured using a
MicroLab 3500 spirometer (Micro Medical Ltd,
Rochester, UK). Following the initial spirometric
assessment, patients took a dose of 400 mg of their
regular beta-agonist inhaler (salbutamol, or terbu-
taline in on case), and spirometry was repeated
after 20min.
Skin testing
Skin prick tests (ALK UK Soluprick) using seven
common aeroallergens were administered: six mix
grass pollen (205,214,218,223,225,228), three mix
tree pollen (106,108,113), house dust mite (Der-
matophagoides Pteronyssinus), cat dander, dog
dander, indoor fungus (Aspergillus Fumigatus), out-
ARTICLE IN PRESS
1182 C. Bobb, T. Ritz
door fungus (Cladosporium Herbarum). Histamine
and saline solutions were also administered as
positive and negative control for comparison. Tests
were performed on the volar aspect of the forearm
more than 5 cm above distal skin crease at the
wrist. The test site was observed at 15min after
the test for the presence of wheal and erthema
formation. A wheal size X3mm was regarded as
being positive.27 All 54 patients had a positive
reaction to the histamine control, and none had a
reaction to the saline control. Antihistamines were
discontinued 48 h prior to the test.
Analysis
Equivalence of groups in dependent variables at
baseline was initially tested by one-way ANOVA with
multiple T-test comparison, or by non-parametric
Kruskal–Wallis test, Mann–Whitney U-test or w2 test
where appropriate. Main outcome measures were
analyzed by two-way repeated measure analysis of
variance (ANOVA) with group (SAC, SAA, SPT) and
time (baseline, follow-up) as variables. Changes in
reliever use were calculated within each group by
Wilcoxon rank-sum test. It was expected that
clinical control of asthma (symptoms, lung function,
and perceived control) would improve specifically in
SAA and even further in SPT. A significance level of
Po0:05 was set for all tests. Effect sizes were
calculated to allow calculation of sample sizes
necessary for future large-scale evaluations.28,29
Results
Baseline assessment
The three patient groups were largely equivalent
in demographic and asthma-related variables
(Table 1), as well as the ATI subscales (follow-up
scores used for SAC group). A large percentage of
patients were treated according to Step 2 or 3 of
the BTS guidelines.1 No significant group differ-
ences were found for knowledge on avoidance
measures (Table 2). Knowledge was low for irritants
(SAA: 26.2%, SPT: 23.7%) and other non-specific
triggers factors (SAA: 14.5%, SPT: 7.9%). SAA and
SPT were roughly equivalent in perception of their
major triggers. One or more allergens were
perceived by 63.2% of SAA and 81.3% of SPT
(63.2% of SAC at follow-up) patients as major
triggers, and one or more non-specific triggers by
94.7 of SAA and 93.8% of SPT (94.7 of SAC at follow-
up). Only one patient in SPT perceived ‘mould’ as a
major trigger factor. Across SAA and SPT, reported
major triggers (house dust, animals, pollen) were
not related to respective knowledge of avoidance
measures. For SPT, there was a strong discrepancy
between the number of patients who reported
the respective allergen as their main trigger,
and number of patients who actually tested
positive for the allergen. There were no group
differences for baseline values of outcome mea-
sures (Table 3).
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Table 1 Demographics, asthma-related variables and lung function at baseline.
SAC (n ¼ 19) SAA (n ¼ 16) SPT (n ¼ 19)
Sex, women, % of group 47.4% 43.8% 52.6%
Ethnic origin, White European, % of group 84.2% 87.5% 68.4%
Education, A-levels & degree, % of group 10.5% 31.3% 26.3%
Smoking, current non-smoker, % of group 63.2% 93.8% 68.4%
Family history of asthma, positive, % of group 84.2% 68.8% 63.2%
BTS treatment step, % of group
Step 1 15.8% 6.3% 21.1%
Step 2 31.6% 50.0% 57.9%
Step 3 42.1% 37.5% 15.8%
Step 4 10.5% 6.3% 5.3%
Age, years (SD) 40.3 (11.9) 38.3 (8.6) 31.8 (11.9)
Age at asthma onset, years (SD) 23.1 (15.8) 16.9 (15.9) 18.9 (11.5)
Asthma-related GP visits, previous year (range) 1.7 (0–8) 1.9 (0–6) 1.3 (0–5)
E&A visits, lifetime (range) 2.1 (0–15) 3.6 (0–30) 1.5 (0–10)
Days of oral steroids, previous year (range) 1.3 (0–14) 2.1 (0–14) 1.2 (0–7)
Limitation on physical activity, rating 0–3 (SD) 1.3 (0.9) 1.6 (0.8) 1.3 (0.5)
FEV1% predicted (SD) 88.8 (16.1) 87.9 (15.1) 87.7 (21.6)
FEV1 (% predicted) post-bronchodilator (SD) 94.7 (16.8) 97.2 (15.6) 96.3 (21.1)
Bronchodilator: DFEV1 4200ml, % of group 47.4% 56.3% 52.6%
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Intervention effects
At follow-up, one patient in SAA and two patients in
SPT had stopped preventer intake. BTS treatment
steps remained relatively stable for SAC patients
compared to the other groups: only two (10.5%)
patients in SAC had reduced their medication one
step, whereas four (25.0%) patients in SAA and
three (15.8%) patients in SPT had reduced medica-
tion one step, and one (5.3%) patient in SPT had
stepped down three steps. These changes were
almost outbalanced by one (6.7%) patient in SAA
and four (21.1%) patients in SPT stepping up one
step. Reliever use dropped from a weekly to a
monthly use in all groups. No A&E attendance
occurred between baseline and follow-up.
In both intervention groups, perceived frequency
of animal-allergic triggers was increased at follow
up (time effect: Fð1; 33Þ ¼ 7:56; P ¼ 0:010),
whereas frequency of pollen-allergic triggers re-
mained stable. Trigger control increased in SAA only
(Table 3). Perceived control of asthma increased,
and bothering about symptoms decreased in all
three groups, as did restrictions by symptoms at
daytime, nighttime, and on activity, time effects
F(1,51)¼ 9.30, 16.25, and 17.07, all Pso0:001;
respectively. Spirometric lung function was im-
proved at follow-up, mainly due to improvements
in SAA and SPT as shown by the group by time
interaction for FEV1. Effect sizes of SAA and SPT
interventions were moderate for FEV1 and small for
symptoms and perceived control of asthma.
Discussion
This study has demonstrated that a structured
allergy and asthma education intervention in a
primary care asthma clinic improves patients’
asthma control and illness perception. Specific
effects of the interventions were observed in
measures of spirometry, most clearly in FEV1. Both
intervention groups, SAA and SPT, showed compar-
able improvements in lung function at follow-up,
and the SAA group also showed improvements in
perceived asthma trigger control. This is encoura-
ging, particularly since the intervention consti-
tuted only a single nurse-practitioner consultation
session with assessments and advice. Clinical
practice often requires several repeated appoint-
ments with doctors or nurses to stabilize or improve
patients.
Additional non-specific improvements in all
groups are not surprising as all patients had only
received traditional asthma care (without sufficient
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training in inhaler technique and the stepwise
approach) from general practitioners prior to the
study. Thus, the SAC control group received a
minimal intervention in our study. In addition,
measurements of spirometry and critical discussion
of the results would have served to motivate self-
management behaviors. Although non-specific ef-
fects could also be due to factors such as habitua-
tion, placebo- or expectancy effects, or the
Hawthorne effect, improvements in control groups
have also been observed in other asthma self-
management trials 5,30,31 and have been attributed
to better asthma care.32
Both intervention groups reported a higher
frequency of animal-allergic triggers on the ATI at
follow-up, suggesting that the interventions had
increased their awareness of these triggers in
particular. Interestingly, SPT did not profit in terms
of perceived trigger control. One could speculate
whether confrontation of the SPT group with
previously unperceived trigger factors by objective
skin testing actually affected their feeling of
control over trigger factors. However, as both
groups showed stable ratings of perceived trigger
impact, as well as comparable improvements in
symptoms, perceived control of asthma, and lung
function, it is likely that the SPT intervention failed
to affect this aspect of trigger perception selec-
tively.
It is conceivable that longer monitoring periods
across 1 year would reveal a greater impact of SPT
testing on patients’ perceived trigger control. The
impact of avoidance measures (such as removal of a
pet from the household) on allergen levels may
need 12 months to materialize.33 Also, a reduction
in preventative medication might only show
ARTICLE IN PRESS
Table 3 Means, difference scores, and effect sizes for selected outcome measures.
Group Baseline Follow-up Difference scores ANOVA effect Effect size d
Mean (SD) Mean (SD) Mean (95%CI) vs. SAC
ATI trigger impact SACa 2.2 (1.0)
SAA 2.2 (1.0) 2.3 (0.8) 0.04 (0.35–0.43) N/Aa
SPT 2.1 (0.9) 2.1 (0.9) 0.04 (0.25–0.33) N/Aa
ATI trigger control SACa 1.7 (0.9)
SAA 1.4 (0.98) 2.0 (1.0) 0.64 (0.18–1.10) N/Aa
SPT 1.8 (0.97) 1.7 (1.0) 0.06 (0.52–0.41) G T N/Aa
Reliever use SAC 1.6 (1.1) 1.0 (1.2) 0.6 (1.2–0.0)
SAA 1.5 (0.9) 0.9 (0.3) 0.6 (1.2–0.1) 0.00
SPT 1.5 (1.0) 0.7 (1.9) 0.7 (1.4–0.1) Tb 0.08
Symptom frequency SAC 12.6 (7.7) 11.4 (7.8) 1.2 (4.6–2.3)
SAA 11.4 (8.2) 10.2 (5.6) 1.2 (5.6–3.2) 0.03
SPT 11.2 (6.3) 9.1 (7.7) 2.2 (4.9–0.6) 0.20
Symptoms ‘bother’ SAC 0.9 (0.5) 0.7 (0.5) 0.2 (0.4–0.1)
SAA 1.2 (0.5) 1.0 (0.7) 0.2 (0.4–0.1) 0.10
SPT 1.0 (0.5) 0.7 (0.5) 0.3 (0.5––0.1) T   0.36
Perceived control SAC 40.4 (5.4) 40.5 (4.3) 0.1 (2.0–2.1)
SAA 38.4 (5.5) 40.0 (5.6) 1.7 (0.8–3.9) 0.28
SPT 40.1 (5.2) 42.8 (4.9) 2.7 (0.4–4.9) T 0.44
FEV1 SAC 2.84 (0.72) 2.83 (0.77) 0.01 (0.12–0.10)
SAA 2.84 (0.79) 3.06 (0.77) 0.22 (0.10–0.35) 0.63
SPT 2.89 (0.78) 3.18 (0.86) 0.28 (0.07–0.49) T  ; G T 0.64
PEF SAC 403.1 (117.4) 404.9 (113.1) 1.8 (13.2–16.8)
SAA 423.6 (128.0) 462.3 (125.5) 38.7 (2.4–75.0) 0.46
SPT 428.4 (133.3) 454.9 (124.6) 26.5 (1.4–54.5) T   0.38
Po0:05;   Po0:01;   Po0:001; T ; time effect, GT, group by time interaction.
aNot applicable, as for SAC measurements were only taken at follow-up.
bIndividual Wilcoxon–Rank–Sum test for each groups.
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considerable changes during longer monitoring
periods. Seasonal variations in pollen triggers could
have lead to a reduced immediate trigger experi-
ence of some patients throughout the assessment
period. For a number of patients (37.7% of the
sample, no significant difference between groups)
the follow-up assessment took place before the
peak pollen season between June and August. Thus,
although a high percentage of pollen allergies had
been detected in the SPT group, a number of
patients might not have been confronted with this
type of trigger within the observation period.
The level of education in allergen avoidance
measures was rather low in our sample. There was
also a considerable gap between the perceived
major allergic triggers and actual positive skin tests
in SPT. This is consistent with earlier studies.34,35
Ideally, skin testing could play an educational role
by clarifying patients’ allergic status and thus
enabling them to make an informed choice using
the correct avoidance measures.18 Skin testing can
be a valuable aid to nurses to highlight actual
allergens to patients. The procedure can fit into
their existing work routine and is well accepted by
patients.19 Including the test in primary care could
improve the financial burden of prevention mea-
sures on patients. Our findings point out the need
for a greater emphasis on allergen education in
primary care. This could help to reduce asthma
morbidity and mortality, and to avoid unnecessary
referrals to specialist services, which are limited in
number in the UK.36 Introduction of an allergy
nurse practitioner service can significantly reduce
general practitioner consultations and prescribed
medication.37
One potential limitation of this study could be
seen in the lack of a blinded outcome assessor.
Involvement of an additional researcher was not
possible due to limited resources and practice
logistics. However, a contribution through assessor
biases was probably small if any at all, as
questionnaires were filled in by patients in a
separate room from the experimenter, and results
in outcome measures of lung function did not
match the original expectancies of the researchers
(of a superiority of the SPT group) closely. Never-
theless, blind assessors should be a mandatory
feature of a future large-scale study. Due to the
small group size, this small pilot study could also
have lacked power for variables such as perceived
control of asthma and PEF. Based on the effect sizes
it can be calculated that a study of 15 nurses seeing
15 patients each (total of N ¼ 225 patients) over
the course of 1 year would have sufficient power to
achieve significance in these variables at a power of
0.90.29 These numbers compare with larger trials
that have demonstrated significant effects of
asthma education interventions (e.g. 31,38,39). In
terms of practicalities, health care personnel
conducting such a study would need to have
additional training in asthma and allergy manage-
ment including skin prick testing from accredited
institutions (such as the National Respiratory
Training Center in the UK). The individual primary
care practice would have to provide basic facilities
for nurse-led asthma clinic 40 with equipment,
spirometer, skin testing kit, and a professional
environment.
In conclusion, our preliminary results demon-
strate the potential of a structured allergen
education in primary care. Even a limited inter-
vention such as evaluation of allergic triggers and
avoidance advice can lead not only to improve-
ments in perceived control of triggers but also to
actual improvements lung function in patients
suffering from asthma. The structured allergy
evaluation and advice could be included as one
extra 20-min appointment following the initial
assessment. Although no additional effects of skin
testing were observed, further research is war-
ranted as the sample size was small, the observa-
tion period was relatively short, and only a limited
number of potentially beneficial aspects of skin
testing were evaluated in this pilot study.
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